NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March Feb 25, 2026 08:00AM
TD Cowen Reiterates Buy Rating on NewAmsterdam Pharma Co NV (NAMS) Aug 6, 2025 10:18AM
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March Feb 25, 2025 08:00AM
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Dec 13, 2024 05:16PM
NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants Dec 11, 2024 09:37PM


Dec 10, 2024 04:36PM NewAmsterdam Pharma (NAMS) Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Dec 10, 2024 04:34PM NewAmsterdam Pharma Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
Aug 27, 2024 08:18AM TD Cowen Reiterates Buy Rating on NewAmsterdam Pharma Co NV (NAMS)
May 15, 2024 09:21AM TD Cowen Starts NewAmsterdam Pharma Co NV (NAMS) at Buy
Feb 26, 2024 08:00AM NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March
Mar 1, 2023 08:00AM NewAmsterdam Pharma to Present at Cowen 43rd Annual Health Care Conference
Mar 1, 2023 08:00AM NewAmsterdam Pharma to Present at Cowen 43rd Annual Health Care Conference